RT Journal Article
SR Electronic
T1 NETosis is an important component of chronic inflammation in patients with heart failure
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.07.09.24310187
DO 10.1101/2024.07.09.24310187
A1 Kostin, Sawa
A1 Richter, Manfred
A1 Krizanic, Florian
A1 Sasko, Benjamin
A1 Kelesidis, Theodoros
A1 Pagonas, Nikolaos
YR 2024
UL http://medrxiv.org/content/early/2024/07/10/2024.07.09.24310187.abstract
AB Background and aim We have previously demonstrated that heart failure (HF) is characterized by low-grade myocardial inflammation. However, the role of neutrophils (N), neutrophil extracellular traps (NETs) and neutrophil cell death by NETosis in the myocardium of patients with HF remains largely unknown. The present study investigated the number of neutrophils (N) and their proportion undergoing NETosis and developing NETs in HF.Methods We used quantitative confocal microscopy and NETosis markers in the left ventricular biopsies obtained from 5 control and from patients with HF due to dilated (DCM, n=7), inflammatory (infCMP, n=7) and ischemic cardiomyopathy (ICM, n=7). We used immunolabeling for CD45, CD66b and CD11b for (N) and citrullinated histone3 (citH3), peptidylarginine deiminase-4 (PAD-4), neutrophil elastase (NE) and myeoloperoxidase (MPO) for NETosis. These proteins were also investigated by quantitative fluorescence intensity analysis, Western blot and quantitative polymerase chain reaction (qPCR).Results Compared to control, the number of N was increased 3-4 times in HF. We found that using a single marker for NETosemarkers, 43.2% of N in DCM, 46.7% in ICM and 57.3% in infCMP experienced NETosis. The use of double labeling (NE with CitH3) showed that 55.6% of N developed NETosis in DCM, 57.9% in ICM and 79.4% in infCMP. The difference between the N who underwent NETosis in infCMP and those in DCM was statistically different (p<0.01). The proportion of N who developed NETosis or formed NETs in control tissue was less than 5% and differed significantly from that in HF patients, regardless of etiology (p<0.01). These results were confirmed by quantitative fluorescence analysis, Western blot and qPCR.Conclusions This is the first study to show the occurrence of NETosis in human hearts in situ indicating that NETosis is an important component of low-grade myocardial inflammation in HF.What is new?Low-grade myocardial inflammation is a typical feature of heart failure and neutrophil cell death (NETosis) is an important component of this pathological process.What are the clinical implications?Preventing excessive neutrophil activation and inhibiting the major components involved in the NETosis program (neutrophil elastase, myeloperoxidase and peptidylarginine deiminase-4) are perspective targets for the treatment of HF.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNoneAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the ethical committee of the Landesärztekammer Hessen, Frankfurt am Main (project numbers FF 8/2011 and FF 56/2012).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe data underlying this article will be shared on reasonable request to the corresponding authorCMPcardiomyopathycitH3citrullinated histone H3DCMdilated cardiomyopathyHFheart failureICMischemic cardiomyopathyinflCMPinflammatory cardiomyopathyIQRinterquartile rangeMPOmyeloperoxidaseNEneutrophil elastaseNETneutrophil extracellular trapNETosisNET-dependent death of neutrophilsPAD4peptidyl arginine deiminase